The viscosupplementation products segment accounted for the greatest market share in 2017, which is largely attributed to increasing rates of knee and hip joint osteoarthritis among the baby boomer population and decreasing viscosupplementation costs.
Leading market players include:
1. Bone Biologics
2. Medtronic
3. Bioventus
4. Pioneer Surgical Technology
5. Smith & Nephew
6. Stryker
More articles on biologics:
Regenerative medicine company names Susan Vogt to board of directors: 3 notes
SpinalCyte’s CybroCell shows positive results for degenerative disc disease pain relief: 5 insights
Regentis Biomaterials to test knee cartilage repair treatment at 11 U.S. sites: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.